iShares Genomics Immunology and Healthcare ETF Rating $21.19 -0.45 (-2.08%) Closing price 07/11/2025 04:10 PM EasternExtended Trading$21.15 -0.04 (-0.17%) As of 07/11/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock iShares Genomics Immunology and Healthcare ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IDNA Aggregate RatingModerate Buy 2.68Holdings in IDNA have an aggregate rating of Moderate Buy based on 382 analyst ratings issued in the past year covering 33 companies (65.4% of the portfolio).IDNA Aggregate Price Target$21.19High Prediction$21.19Average Prediction$21.19Low Prediction$21.19Holdings in IDNA have an aggregate price target of $21.19 and a range of $21.19 to $21.19 covering 33 companies (65.4% of the portfolio).IDNA Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy12 Buy rating(s)Moderate Buy12 Moderate Buy rating(s)Hold9 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Genomics Immunology and Healthcare ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 33 IDNA Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.74%TWSTTwist Bioscience$38.03-1.1%4.3863 of 5 stars2.70$50.40 32.5%10Gap Down4.41%REGNRegeneron Pharmaceuticals$567.74+1.4%4.8282 of 5 stars2.80$814.57 43.5%25Trending NewsAnalyst ForecastAnalyst Revision4.37%MRNAModerna$33.64-1.9%4.3035 of 5 stars2.04$46.61 38.6%25Trending NewsAnalyst Forecast4.14%MRKMerck & Co., Inc.$83.35-0.8%4.997 of 5 stars2.43$108.69 30.4%21Trending NewsAnalyst ForecastAnalyst Revision4.08%EXELExelixis$44.86-0.7%4.7862 of 5 stars2.48$44.72 -0.3%21Analyst Forecast3.96%BNTXBioNTech$112.89-0.9%1.6314 of 5 stars2.83$137.91 22.2%18News CoverageAnalyst Forecast3.93%INCYIncyte$68.59-2.5%4.7336 of 5 stars2.22$74.53 8.7%183.86%ACLXArcellx$68.98+0.2%2.5604 of 5 stars3.07$111.23 61.3%15Positive News3.59%RVMDRevolution Medicines$38.02-1.2%4.489 of 5 stars3.00$68.00 78.9%113.24%BCRXBioCryst Pharmaceuticals$8.76-1.4%4.2067 of 5 stars2.90$16.70 90.6%102.67%JANXJanux Therapeutics$25.15-1.8%1.903 of 5 stars3.08$91.89 265.4%12News CoverageAnalyst Forecast2.24%NVAXNovavax$6.84-3.7%4.348 of 5 stars2.29$17.00 148.5%71.89%GERNGeron$1.32-4.3%3.3511 of 5 stars2.60$4.61 249.3%10News CoverageAnalyst ForecastGap Down1.88%ABCLAbCellera Biologics$4.01-5.6%2.1267 of 5 stars3.00$7.50 87.0%6News CoverageAnalyst Revision1.65%VERVVerve Therapeutics$11.03-0.3%3.0572 of 5 stars2.33$14.57 32.1%91.49%IMNMImmunome$8.64-3.5%2.0922 of 5 stars3.00$23.33 170.1%6Positive News1.24%XNCRXencor$8.83-4.8%4.4327 of 5 stars2.75$28.00 217.1%8News Coverage1.23%RCUSArcus Biosciences$9.35-2.0%2.1288 of 5 stars2.89$21.29 127.7%9News Coverage1.08%VIRVir Biotechnology$5.65-4.7%3.607 of 5 stars2.86$30.25 435.4%7News CoverageAnalyst Upgrade1.07%IOVAIovance Biotherapeutics$1.87-3.1%4.6848 of 5 stars2.50$12.22 553.6%12Trending News1.07%KURAKura Oncology$6.28-1.3%4.42 of 5 stars2.86$24.50 290.1%14Positive News1.06%DNAGinkgo Bioworks$9.98-7.5%0.7834 of 5 stars2.00$8.50 -14.8%2News CoverageGap Down0.95%ORICOric Pharmaceuticals$11.10-3.1%4.5872 of 5 stars3.00$18.57 67.3%9Analyst Forecast0.93%MREOMereo BioPharma Group$1.61-4.7%1.5624 of 5 stars3.20$7.20 347.2%5News CoverageAnalyst ForecastGap UpHigh Trading Volume0.90%CELCCelcuity$13.63+0.1%2.2907 of 5 stars3.17$28.40 108.4%6Positive News0.88%PACBPacific Biosciences of California$1.47-2.0%1.8378 of 5 stars2.44$2.06 40.2%9News CoveragePositive NewsGap Down0.76%ARCTArcturus Therapeutics$13.78-4.8%1.7377 of 5 stars3.11$54.00 291.9%9Gap Down0.73%RIGLRigel Pharmaceuticals$18.88-3.7%3.0003 of 5 stars2.40$36.40 92.8%5Positive News0.54%IBRXImmunityBio$2.81-2.1%2.3679 of 5 stars3.20$12.25 335.9%5News CoverageAnalyst Forecast0.37%CRSPCRISPR Therapeutics$56.80-3.7%3.236 of 5 stars2.53$71.75 26.3%17News CoverageAnalyst ForecastOptions Volume0.19%LGNDLigand Pharmaceuticals$121.70-2.6%4.0755 of 5 stars3.00$147.17 20.9%6News CoverageInsider Trade0.15%BEAMBeam Therapeutics$21.16-3.9%2.0948 of 5 stars3.00$48.75 130.4%15News Coverage0.09%NTLAIntellia Therapeutics$11.53-5.2%4.3486 of 5 stars2.65$33.37 189.4%20 This page (NYSEARCA:IDNA) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Genomics Immunology and Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Genomics Immunology and Healthcare ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IDNA Stock Alerts